INS and diabetes mellitus: B lymphocyte-depleted individuals had a delayed decline of endogenous insulin production, measured by C-peptide (4, 5), and B cell depletion therapy in mouse models has both provided protection from diabetes when administered in prediabetic mice and reversed diabetes when administered after diabetes onset (6).